Skip to Main Content

Paper Details

Chronic neuropsychiatric sequelae of SARS-CoV-2: Protocol and methods from the Alzheimer's Association Global Consortium.
Alzheimers Dement (N Y)
12
2022
AD, ADRD, Alzheimer's, Alzheimer's disease, CNS, COVID, COVID-19, Chronic Neuropsychiatric Sequelae, Coronavirus disease, SARS-CoV, SARS-CoV-2, SARS-CoV-2 infection, cognitive decline, cognitive impairment, dementia, dementias, loss of sense of smell or taste, neurologic illness, neurologic problems, neurological injury, neurological symptoms, neuropsychiatric sequelae, patients, people, pulmonary illness, seizures, stroke, vascular disease
Author NameAffiliation
Rufus AkinyemiUniversity of Ibadan Ibadan Nigeria.
John BlangeroInstitute of Neuroscience University of Texas Rio Grande Valley Harlingen Texas USA.
Vincent Lo ReIstituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione Istituto di Ricovero e Cura a Carattere Scientifico (ISMETT-IRRCS) Palermo Italy.
Filippo Martinelli BoneschiUniversita degli Studi di Milano Milan Italy.
Carla GalloLaboratorios de Investigacion y Desarrollo Facultad de Ciencias y Filosofia Universidad Peruana Cayetano Heredia Lima Peru.
Thomas H MosleyUniversity of Mississippi University Hospital Oxford Mississippi USA.
Timothy D GirardUniversity of Pittsburgh School of Medicine Pittsburgh Pennsylvania USA.
  • 1 - 7

Datasets